Expression and function role of DNA methyltransferase 1 in human bladder cancer.
Department of Urology, Chang Gung Memorial Hospital, Keelung, Taiwan.
- Published Article
Wiley (John Wiley & Sons)
- Publication Date
Nov 15, 2011
DNMT1 could be a significant clinical predictor for stage and treatment response of bladder cancer. Moreover, targeting this enzyme could be a promising strategy for treating bladder cancer, as evidenced by inhibited tumor growth and enhanced radiosensitivity.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 04/18/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/21523767